Boris Gorovitz
Company: Sana Biotechnology
Job title: Vice President, In vitro Pharmacology, Biomarker Discovery & Bioanalysis at Development Sciences
Seminars:
Have The Speakers Answer Your Questions 10:30 am
day: Day One
Evaluation Of Antibody-Based Immunity Against Viral Gene Therapy Modalities 9:00 am
High prevalence of pre-existing anti-gene therapy has been reported and is typically evaluated prior to treatment. Induction of post-dose antibody response is expected Appropriate assessment of potential subjects often includes evaluation for the neutralizing of the total antibody anti-gene therapy Recommendations for NAb and TAb methods, including suggestions for key assay parameters will be discussedRead more
day: Day One